Form 4: Phathom Pharmaceuticals CFO Reports Stock Transaction
Insider Transaction (Form 4)
Sanjeev Narula, Chief Financial & Bus. Officer of Phathom Pharmaceuticals, Inc., reported a transaction in 13,485 shares of common stock on October 6, 2026.
Summary
- Tax/exercise-price withholding: disposed of 13,485 Common Stock at $6.78 ($91,428) on October 6, 2026; holds 214,718 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sanjeev Narula — Officer (Chief Financial & Bus. Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Tax/exercise-price withholding | Common Stock | 13,485 | $7 | $91.4K | 214,718 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Tax/exercise-price withholding (13,485 shares) |
Keywords
insider transaction, Form 4, PHAT, Phathom Pharmaceuticals, Inc., neutral, Sanjeev Narula
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.